The unique characteristics of COVID-19 coagulopathy

T Iba, JH Levy, JM Connors, TE Warkentin, J Thachil… - Critical care, 2020 - Springer
Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the
characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen …

Proposal of the definition for COVID-19-associated coagulopathy

T Iba, TE Warkentin, J Thachil, M Levi… - Journal of clinical …, 2021 - mdpi.com
Thrombotic events are common complications in COVID-19 patients that include both
thrombus formation in large vessels and the microvasculature of the lung and other organs …

COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation

JK Salabei, TJ Fishman, ZT Asnake, A Ali, UG Iyer - Heart & Lung, 2021 - Elsevier
Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …

[HTML][HTML] Coagulopathy in COVID‐19

T Iba, JH Levy, M Levi, J Thachil - Journal of thrombosis and haemostasis, 2020 - Elsevier
The COVID‐19 pandemic has become an urgent issue in every country. Based on recent
reports, the most severely ill patients present with coagulopathy, and disseminated …

COVID-19 and its implications for thrombosis and anticoagulation

JM Connors, JH Levy - Blood, The Journal of the American …, 2020 - ashpublications.org
Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-
induced infection can be associated with a coagulopathy, findings consistent with infection …

COVID-19 coagulopathy vs disseminated intravascular coagulation

M Levi - Blood advances, 2020 - ashpublications.org
Patients with severe COVID-19 infections frequently manifest coagulation abnormalities that
are associated with respiratory deterioration and death. In addition, many patients with …

Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy—either, neither, or both

M Levi, J Thachil - Seminars in Thrombosis and Hemostasis, 2020 - thieme-connect.com
Patients with severe coronavirus disease 2019 (COVID-19) infections manifest coagulation
abnormalities that have been associated with respiratory deterioration and death. 1, 2 In …

Coagulopathy associated with COVID-19

SG Lee, M Fralick, M Sholzberg - CMAJ, 2020 - Can Med Assoc
Coagulopathy correlates with severity of COVID-19 and may include increased d-dimer
concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s …

Covid-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome

M Ranucci, C Sitzia, E Baryshnikova… - Journal of clinical …, 2020 - mdpi.com
Background: Coronavirus Disease 2019 (COVID-19)-associated coagulopathy is
characterized by a prothrombotic state not yet comprehensively studied. We investigated the …

Coagulopathy and COVID-19

FL Lorini, M Di Matteo, P Gritti, L Grazioli… - European Heart …, 2021 - academic.oup.com
SARS-CoV-2 infection is associated with frequent thrombotic events, at the micro and macro-
vascular level, due to the perpetuation of a state of hypercoagulability. The so-called 'COVID …